Rationale The neuroactive steroid (3α,5α)-3-hydroxypregnan-20-one (3α,5α-THP, allopregnanolone) has effects on reward-related behaviors in mice and rats that suggest that it may activate brain reward circuits. Intracranial selfstimulation (ICSS) is an operant behavioral technique that detects changes in the sensitivity of brain reward circuitry following drug administration. Objective To examine the effects of the neuroactive steroid allopregnanolone on ICSS and to compare these effects to those of cocaine. Methods Male C57BL/6J mice implanted with stimulating electrodes implanted into the medial forebrain bundle responded for reinforcement by electrical stimulation (brain stimulation reward (BSR)). Mice received cocaine (n=11, 3.0-30.0 mg/kg, intraperitoneal (i.p.)) or the neuroactive steroid allopregnanolone (n=11, 3.0-17.0 mg/kg, i.p.). BSR thresholds (θ 0 ) and maximum (MAX) operant response rates after drug treatments were compared to those after vehicle injections. Results Cocaine and allopregnanolone dose dependently lowered BSR thresholds relative to vehicle injections. Cocaine was maximally effective (80 % reduction) in the second 15 min following the 30 mg/kg dose, while allopregnanolone was maximally effective (30 % reduction) 15-45 min after the 17 mg/kg dose. Neither drug had significant effects on MAX response rates. Conclusions The effects of allopregnanolone on BSR thresholds are consistent with the previously reported effects of benzodiazepines and alcohol, suggesting that positive modulation of GABA A receptors can facilitate reward-related behaviors in C57BL/6J mice.
Introduction
Since its discovery as a potent allosteric modulator of GABA A receptors, the endogenous neuroactive steroid (3α,5α)-3-hydroxy-pregnan-20-one (3α,5α-THP, allopregnanolone) has been shown to affect a wide array of behaviors in species as diverse as salamanders and human beings. Roles for endogenously synthesized allopregnanolone have been proposed in reproductive and aggressive behaviors, learning and memory, mood and anxiety, and drug use and withdrawal, while dysregulation of allopregnanolone has been associated with psychiatric conditions such as pre-menstrual dysphoria, depression, and schizophrenia (Brinton 2013; Marx et al. 2006; Rasmusson et al. 2006; Rupprecht et al. 2010) . Though the effects of allopregnanolone likely involve potentiation or direct activation of GABA A receptors (see Morrow (2007) for review), which are associated with GABA-mediated Cl − influx and cellular inhibition, allopregnanolone alters many behaviors in ways that are similar to those of drugs that enhance the mesolimbic dopamine (DA) system. Allopregnanolone can stimulate locomotor activity in mice (Finn et al. 1997b; Palmer et al. 2002) , enhance sexual receptivity and motivation in female rats and hamsters (Frye et al. 1998; Frye and DeBold 1993) , facilitate responding for different reinforcers in both mice and rats (Fish et al. 2002; Janak et al. 1998; Sinnott et al. 2002b) , increase or decrease mouse aggressive behavior in particular testing conditions (Fish et al. 2001; Pinna et al. 2003) , and induce conditioned place preference in mice (Finn et al. 1997a) . Certain drugs of abuse, including alcohol, can elevate allopregnanolone levels in the brain as well as the bloodstream, effects that are most consistently observed in rats (Concas et al. 2000; Cook et al. 2014a; Grobin et al. 2005; Morrow et al. 1999; QuinonesJenab et al. 2008) , and allopregnanolone appears to contribute some of the behavioral effects of alcohol (VanDoren et al. 2000) . Interestingly, intracerebroventricular (icv) allopregnanolone administration biphasically alters extracellular DA levels in the mesocorticolimbic circuitry (RougePont et al. 2002) , and allopregnanolone is thought to be the mechanism through which progesterone sensitizes DA elevations induced by alcohol (Dazzi et al. 2002) . A common effect of drugs that directly and/or indirectly enhance dopaminergic neurotransmission is to increase operant intracranial self-stimulation (ICSS). ICSS measures the responding of an animal for reinforcement by direct electrical stimulation of brain reward circuitry. Stimulation of the medial forebrain bundle, which contains ascending dopaminergic projections from the ventral tegmental area, as well as descending glutamatergic and GABAergic projections from the cortex and nucleus accumbens (NAc), elicits robust and reproducible brain stimulation reward (BSR). Drugs of abuse with widely differing pharmacological mechanisms of action all potentiate BSR (Kornetsky and Bain 1992 ). An essential role for DA in BSR is supported by pharmacological studies administering indirect agonists, specific DA receptor agonists and antagonists, as well as in vivo measures of extracellular DA levels (Carlezon and Chartoff 2007; Wise 1996) . However, the full expression of ICSS requires not only DA but also the integrated functions of glutamate and GABA (Cheer et al. 2005) as well as cholinergic actions in the ventral tegmental area (VTA) (Wise 2002) . While the glutamatergic (Herberg and Rose 1990; Todtenkopf et al. 2006; You et al. 2001 ) and cholinergic contributions, especially in regard to nicotine (Huston-Lyons and Kornetsky 1992; Kenny and Markou 2006; Singh et al. 1997) , to ICSS have been well characterized; the role of GABA in ICSS has been studied less frequently. Pharmacological studies have demonstrated a potentiation of ICSS by benzodiazepines (Caudarella et al. 1982; Reynolds et al. 2012; Straub et al. 2010 ) and alcohol (Fish et al. 2010; Robinson et al. 2013 ) consistent with abuse of these substances by humans. However, the role of GABA in reward processing is complex, and other studies have shown that direct GABA agonists depress ICSS (Hayes et al. 2011; Willick and Kokkinidis 1995) . Given that allopregnanolone can alter extracellular DA levels in mesocorticolimbic regions and produces behavioral and neurophysiological effects that are similar to those of benzodiazepines and alcohol, we hypothesized that allopregnanolone could also potentiate ICSS. The present study examined the effects of allopregnanolone on ICSS in male mice and compared these effects to those of the pharmacological reference compound cocaine.
Methods

Mice
The cocaine and allopregnanolone dose-response experiments were conducted in separate groups of experimentally naïve male C57BL/6J mice (Jackson Laboratories, Bar Harbor, ME; n=11 for each group). The effects of allopregnanolone were further replicated in an additional replicate of mice with a different experimental history. This replicate consisted of 11 male C57 mice with a humanized mutation of the mu opioid receptor (h/mOPRM1-118AA (n=5) or h/mOPRM1-118GG (n=6) (Ramchandani et al. 2011 ) that had previously been treated with the mu opioid receptor agonist fentanyl and the kappa opioid receptor agonist U69,593 (n=8) or the opioid receptor agonist morphine and cocaine (n=3) (Robinson et al. in prep) . When the mice were at least 60 days old, monopolar stainless steel electrodes (0.28-mm diameter, Plastics One, Roanoke, VA) were stereotaxically implanted to the right medial forebrain bundle at the level of the lateral hypothalamus (LH) (AP −1.2; ML −1.0; DV −5.2 from the skull) under anesthesia with ketamine (120 mg/kg) and xylazine (9 mg/kg) (Sigma, St. Louis, MO). The electrode was connected to a stainless steel electrical ground screw and was mounted to the skull with dental cement. Following implantation, the mice were housed individually in polycarbonate cages (28×17× 14 cm) that were lined with cob bedding that was changed weekly and covered with stainless steel wire lids. The mice had free access to food (TestDiet) and tap water. The vivarium was 21±1°C, 30-40 % humidity, and on 12-h dark/light cycle (lights off at 8:00 a.m.). All procedures were performed during the dark phase and were approved by the Institutional Animal Care and Use Committee (IACUC) of the University of North Carolina and were conducted according to the Guide for the Care and Use of Laboratory Animals (NIH publication no. 85-23, revised 2011).
Apparatus and procedures
Testing occurred in sound-attenuated operant conditioning chambers as previously described (Fish et al. 2010; Malanga et al. 2008; Robinson et al. 2012) . Computers running control software (MED-PC for Windows, version 4.1; Med Associates; St. Albans, VT) recorded wheel spin responses
(1/4 turn), activated house lights, and issued stimulation to the electrodes through a swivel commutator and insulated wire (Plastics One, Roanoke, VA). Each response was reinforced by a brief (500 ms) unipolar cathodal square-wave current at a frequency of 158 Hz (pulse width=100 μs) accompanied by illumination of the house light (500 ms). Responses during the stimulation period were recorded but did not earn additional stimulation. Current intensity was adjusted for each individual mouse and held constant throughout the experiment to maintain at least 40 responses/min (−40 to −150 μA). Ratefrequency curves were generated as the mice responded for a series of decreasing (0.05 log 10 ) stimulation frequencies. Stimulation at each frequency was available ad libitum for 50 s initiated by a 10-s phase during which five noncontingent ("priming") stimulations were presented. During conditioning, each series of 15 frequencies was presented four times (60-min session), and the range of frequencies (therefore, total charge delivered) was adjusted so that the mice only responded during the 3-5 highest frequencies and did not respond during the remaining 12-10 lowest frequencies. When BSR thresholds varied less than 10 % on three consecutive days, the mice were habituated to injections and drug testing phases began. The mice were approximately 90 days old at the start of the drug testing. Following a 45-min preinjection baseline (i.e., three series of 15 descending frequencies), the mice were removed from the chamber, injected with either cocaine (saline, 3, 10, and 30 mg/kg, intraperitoneal (i.p.)) or allopregnanolone (BCD vehicle, 3, 5.6, 10, and 17 mg/kg, i.p.), and returned immediately to the operant chambers for 60 min during which four series of 15 descending stimulation frequencies were presented. Each drug dose was administered in a random order and separated by at least 48 h.
Drugs
Cocaine hydrochloride (Sigma, St. Louis, MO) was dissolved in 0.9 % saline, and allopregnanolone [(3α,5α)-3-hydroxypregnan-20-one, purchased from Robert H. Purdy] was s u s p e n d e d w i t h s o n i c a t i o n i n a 2 0 % ( w / v ) hydroxypropyl-β-cyclodextrin (Acros Organics, Fairlawn, NJ) solution. For cocaine, doses were calculated as the free base. All drugs were injected intraperitoneally in a volume of 1 ml/100 g body weight.
Histology At the end of the ICSS experiment, the mice were deeply anesthetized with sodium pentobarbital (120 mg/kg) and intracardially perfused with 0.9 % saline followed by 4 % paraformaldehyde in 0.1 M PBS. The brains were removed and sectioned (50 μm) on a sliding microtome and stained with cresyl violet for Nissl to determine the location of the most ventral electrode tip placements under low-powered (4×) light microscopy ( Fig. 1 ).
Data analysis
Customized software analyzed each rate frequency curve to determine the maximum (MAX) response rate and to derive, from least squares regression, the EF 50 (the frequency that maintained 50 % of maximum responding) and the BSR threshold θ 0 (the x-intercept or minimum frequency that maintained ICSS responding). For each mouse, data following drug or vehicle injections were then normalized to a percent of that individual's vehicle baseline. All data were analyzed using a one-way repeated measure analysis of variance (ANOVA) with cocaine or allopregnanolone dose as the within subject factor. Significant F tests were further analyzed using Bonferroni-corrected post hoc tests to determine doses that were significantly different from the vehicle control at the p<0.05 level.
Results
The ventral most electrode placements are shown in Fig. 1 throughout the right medial forebrain bundle in the LH. There was a similar distribution of electrode placements and similar pre-injection baseline responding for the mice treated with cocaine and the mice treated with allopregnanolone; BSR thresholds, EF 50 s, and MAX response rates were 2.3±0.2 Coulomb (C) 10 , and 133±7.4 responses/50 s for the allopregnanolone-treated mice.
Cocaine
Cocaine dose dependently lowered BSR threshold in each 15-min time period after injection (Fig. 2a, F 3 ,43 =27.9, 48.9, 33.2, and 8.2 for the first, second, third, and fourth 15 min, respectively; all p's<0.001). Cocaine also lowered the EF 50 (Table 1. F 3,43 =9.9, 36.3, 19 .4, and 6.5 for the first, second, third, and fourth 15 min, respectively; all p's<0.001). Post hoc comparisons versus the saline control revealed that the 3 mg/kg dose lowered the EF 50 by 18±3.8 % in the first 15 min, that the 10 mg/kg dose significantly lowered BSR threshold by 50±7.2 and 11±3.9 % in the first and second 15 min, respectively, and lowered the EF 50 by 30±4.1 and 20±2.6 % in the first and second 15 min, respectively, and that the 30 mg/kg dose significantly lowered BSR threshold by 75±5.3, 85±2.6, 72±6.0, and 48±7.6 %, respectively, in the first, second, third, and fourth 15-min time period, respectively. The 30 mg/kg dose also lowered the EF 50 by 37±6.6, 50±3.8, 46±4.3, and 32±6.3 % in the first, second, third, and fourth 15-min time period, respectively, in each 15-min period. No dose of cocaine significantly affected MAX response rates as compared to the saline control (Fig. 2b) .
Allopregnanolone
Allopregnanolone dose dependently lowered BSR threshold and the EF 50 in the second (F 4,54 =4.1; p=0.01, Fig. 3a ; F 4,54 = 3.3; p=0.02, Table 1 ) and third (F 4,54 =3.0; p=0.03, Fig. 3a ; F 4,54 =3.9; p=0.01, Table 1 ) 15-min time periods. Relative to the vehicle injection, the 17 mg/kg dose lowered BSR threshold and the EF 50 by 33±9.0 and 15±3.4 %, respectively, in the second 15-min time period. In the third 15-min time period, the 17 mg/kg dose lowered BSR threshold and the EF 50 by 23 ±5.6 and 18±5.1 %, respectively. There were no significant effects of allopregnanolone on BSR threshold or the EF 50 in the first or fourth 15-min time period. There were no significant effects of allopregnanolone on MAX response rates in any of the 15-min time periods.
Similar effects of allopregnanolone were achieved when the allopregnanolone was further tested in an additional replicate of mice (Table 2 ). In this second replicate, the 10 mg/kg dose significantly lowered BSR threshold in the second 15-min time period and the EF 50 in the third 15-min time period. The 17 mg/kg dose significantly lowered BSR threshold in the third 15-min time period. There were no significant effects of allopregnanolone on MAX response rates.
Discussion
These experiments compared the effects of different doses of the neuroactive steroid allopregnanolone on ICSS, a behavioral measure of the sensitivity to rewarding brain stimulation. The psychomotor stimulant cocaine was also tested as a pharmacological reference. Allopregnanolone, like cocaine, dose dependently potentiated ICSS in male C57 mice by lowering the amount of stimulation that was necessary to maintain ICSS responding, as measured by both the EF 50 and the θ 0 , two indices of the self-stimulation threshold. These effects were significant for the 17 mg/kg dose between 16 and 45 min after allopregnanolone injection. A possible effect of allopregnanolone on operant motor behavior was not evident, as there were no significant increases in MAX response rate after any allopregnanolone dose. Overall, these results are consistent with previous findings that other GABA A -receptor-positive allosteric modulators, such as benzodiazepines and alcohol, can potentiate BSR (Fish et al. 2010; Reynolds et al. 2012; Straub et al. 2010) .
Allopregnanolone was tested in two separate replicates of mice, one which had a prior drug history and one that was experimentally naive. Two important features of ICSS are that BSR thresholds remain stable over time (Carlezon and Chartoff 2007; Riday et al. 2012b ) and the sensitivity to pharmacological manipulation does not change after prior experience with psychostimulants or opioids (Esposito and Kornetsky 1977; Frank et al. 1988; Riday et al. 2012b ). The dose-dependent effects of allopregnanolone on ICSS were qualitatively similar in each of the replicates, supporting the validity of testing different pharmacological classes of drugs in the same individuals Malanga et al. 2008; Riday et al. 2012a ) and strengthening the conclusion that allopregnanolone potentiates BSR in C57BL/6J mice. Whether repeated allopregnanolone treatment induces tolerance and/or sensitization to its effects on BSR is a question for further study. Additionally, there are species and strain differences in response to allopregnanolone, and it is not known how these results would generalize to rats or to different mouse strains (Finn et al. 1997b; Porcu et al. 2010 ) (see Porcu and Morrow 2014) The largest effects of allopregnanolone on ICSS in C57BL/ 6J mice occurred after the 10 and 17 mg/kg doses, a dose range that is consistent with other behavioral effects of allopregnanolone, such as locomotor stimulation (Finn et al. 1997b; Palmer et al. 2002) , escalated aggression (Fish et al. 2001) , reduction of anxiety-like behaviors (Bitran et al. 1991; Brot et al. 1997; Fish et al. 2000) , and alcohol consumption (Ford et al. 2005) . The 17 mg/kg dose allopregnanolone significantly lowered self-stimulation thresholds by about 30 %. This degree of reduction was of a similar magnitude to the effects observed immediately after 3 mg/kg dose of cocaine and was modest compared to the maximal effects of the 30 mg/kg dose of cocaine. Moderate reductions in BSR thresholds have been reported for the benzodiazepines diazepam (Reynolds et al. 2012 ) and midazolam (Engin et al. 2014) as well as for alcohol (Fish et al. 2010) , indicating that GABA A -receptor-positive modulators can potentiate BSR, although not to the same degree as psychostimulants. The time course for allopregnanolone followed previously reported brain levels of allopregnanolone after systemic administration which peak within 10 min and which are metabolized rapidly into forms that do not affect GABA A receptors (Mellon et al. 2008; Purdy et al. 1990 ). An alternative to allopregnanolone treatment is the synthetic neurosteroid ganaxolone, which has a longer half-life (Carter et al. 1997 ) and may be useful for the treatment of epilepsy (Reddy 2010) . Future measurements of the effects of ganaxolone on ICSS may uncover influences on brain reward that could be related to its effects on alcohol intake in rodents (Besheer et al. 2010; Ramaker et al. 2012 ) and have implications for its clinical use. The potentiation of BSR is consistent with the findings that lower doses of allopregnanolone and ganaxolone can facilitate some other operant behaviors, including fixed interval responding for the opportunity for aggression (Fish et al. 2002) , fixed ratio responding for alcohol administration (Besheer et al. 2010; Janak et al. 1998; Ramaker et al. 2012) , and the reinstatement of extinguished responding for alcohol (Finn et al. 2008) . Some evidence also suggests that allopregnanolone has reinforcing effects of its own as mice will orally self-administer allopregnanolone (Sinnott et al. 2002a ) and develop a conditioned place preference (Finn et al. 1997a) , but see Beauchamp et al. (2000) . The current results are not interpreted to reflect a direct reinforcing effect of allopregnanolone. Instead, allopregnanolone, like many drugs that are self-administered, enhances sensitivity to BSR. This enhanced sensitivity combined with the above mentioned increased responding for certain reinforcers suggests that one of the effects of allopregnanolone may be an overall increase in the salience of positive reinforcement. In contrast to this hypothesis are the findings that allopregnanolone, especially at higher doses, inhibits responding in rats reinforced by cocaine or food administration (Anker and Carroll 2010; Schmoutz et al. 2014) as well as the reinstatement of extinguished responding for cocaine (Anker et al. 2009; Schmoutz et al. 2014) . Allopregnanolone can attenuate cocaine-induced seizures (Kaminski et al. 2003) , and high doses of other neuroactive steroids can decrease the sensitivity to the discriminative stimulus effects of cocaine (Quinton et al. 2006 ) and alter cocaine-induced conditioned place preference (Romieu et al. 2003) . The findings of these studies indicate that allopregnanolone influences several effects of cocaine and that allopregnanolone may differentially alter specific forms of reward and reinforcement. An important consideration, which cannot be directly addressed in the current study, is whether allopregnanolone potentiates BSR through a DA-dependent mechanism, as do many other drugs that potentiate BSR and stimulate locomotor behavior (Wise 2002) or if its actions are independent of DA, as has been suggested for the effects of benzodiazepines (Straub et al. 2010 ). There are numerous interactions between allopregnanolone and DA that suggest that DA could be involved in the effects of allopregnanolone on BSR. For example, in the VTA, allopregnanolone co-localizes with tyrosine hydroxylase, the rate-limiting enzyme in DA biosynthesis (Cook et al. 2014b) where it may modulate local excitability (Akk et al. 2005; Sanna et al. 2004 ). Ganaxolone and benzodiazepines can act on DA neurons in the VTA and enhance long-term potentiation (Tan et al. 2010; Vashchinkina et al. 2014) , an effect associated with altered place conditioning. Moreover, pharmacological antagonists to DA receptors attenuate the promotion of lordosis behavior by VTA allopregnanolone in female rats (Frye et al. 2004 ).
While the above evidence supports the idea that DA might also be involved in the effects of allopregnanolone on BSR, Straub et al. (2010) hypothesized that the potentiating effects of benzodiazepines on BSR are due to direct inhibition of medium spiny neurons in the NAc, which has been proposed as important for reward processing (Carlezon and Thomas 2009) . It is not known whether allopregnanolone modulates these medium spiny neurons, but a GABAergic mechanism is thought to inhibit NAc core neurons following MFB stimulation (Cheer et al. 2005) . Neurons expressing the GABA A receptor α2 subunit are critical for the BSR-potentiating effects of diazepam (Reynolds et al. 2012 ) and midazolam (Engin et al. 2014) , and extrasynaptic α4 subunit containing GABA A receptors in the NAc modulates the place conditioning effects of cocaine (Maguire et al. 2014) , indicating the ability of specific GABA A receptors to influence measures of reward. Given the roles of both DA and GABA in the neural control of reward and reinforcement processing and the fact that neuroactive steroids modulate components of both of these neurotransmitters, it is tempting to speculate that allopregnanolone may be an endogenous positive modulator of mesocorticolimbic reward circuits. Continued investigations with the ICSS technique may help to resolve whether the facilitation of BSR by allopregnanolone is predominantly dopaminergic or GABAergic.
